Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 27, 2017
Pharmacy Choice - News - Drug Delivery Systems - March 27, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 87     Next >>     Go To Page:

3/27/17 - "Hypotensive Lipid-Containing Biodegradable Intraocular Implants and Related Implants" in Patent Application Approval Process (USPTO 20170065612)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventor Hughes, Patrick M., filed on November 21, 2016, was made available online on March 16, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or instit
3/27/17 - Bemis Company Receives Multiple Awards from the Flexible Packaging Association
By a News Reporter-Staff News Editor at Pharma Business Week Bemis Company, Inc. has been recognized by the Flexible Packaging Association during its 61st annual awards program for the Hunt's Recipe Ready tomato paste pouch and the NFI/UPM Pharmaceuticals' Lidocare? pain relief patch pouch. The NFI/UPM Pharmaceuticals' Lidocare? pain re
3/27/17 - CURE Pharmaceutical To Exhibit at the 8th Global Drug Delivery & Formulation Summit
CURE Pharmaceutical, or, a leading disruptive drug delivery technology company serving the pharmaceutical, biotech, veterinarian, medical foods markets, cannabinoid molecules and new chemical entities, today announces it will be exhibiting at the 8 th Global Drug Delivery& Formulation Summit in Berlin, Germany March 27-29, 2017. The DDF Summit
3/27/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 13608) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Anesthetic and Analgesic Drug Products Advisory Committee to discuss new drug application 209777, for oxycodone hydrochloride immediate-release oral tablets with the proposed indication of management of moderate to severe pain where the use of an opioid
3/27/17 - Impax Board of Directors Appoints Paul M. Bisaro President and CEO
Impax Laboratories, Inc. today announced that its Board of Directors has appointed Paul M. Bisaro as Impax's President and Chief Executive Officer and a member of the Company's Board, effective March 27, 2017. "We are pleased to have Paul, a highly respected and accomplished leader, with a strong track record of delivering superior shareholder r
3/27/17 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive...
By a News Reporter-Staff News Editor at Pharma Business Week Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an investigational oxybate product candidate with 90 percent less sodium content than Xyrem oral solution, as a potential treatment for cataplexy and excessive
3/27/17 - New Drug Delivery Systems Study Findings Have Been Reported by Researchers at Soochow University (Smart surface coating of drug nanoparticles with...
New Drug Delivery Systems Study Findings Have Been Reported by Researchers at Soochow University. According to news reporting originating from Jiangsu, People's Republic of China, by VerticalNews correspondents, research stated, "Many drug molecules can be directly used as nanomedicine without the requirement of any inorganic or organic carriers su
3/27/17 - Opiant Pharmaceuticals, Inc. Announces Results of Positron Emission Tomography (PET) Study of Naloxone Nasal Spray
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing pharmacological treatments for addictions and eating disorders, today announced the completion of a study evaluating two doses of a naloxone nasal spray on the occupation of brain opiate receptors using PET imaging. The study was commissioned by the National Institute for
3/27/17 - Patent Issued for Arrangement for Use in a Drug Delivery Device (USPTO 9592341)
By a News Reporter-Staff News Editor at Diabetes Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Jugl, Michael; Sendatzki, Gunther; Teucher, Axel; Forstreuter, Axel; Donig, Rainer, filed on October 14, 2010, was published online on March 14, 2017. The patent's assignee for patent number 9592341 is SANOFI-A
3/27/17 - Patent Issued for Combination Unit Dose Dispensing Containers (USPTO 9592354)
By a News Reporter-Staff News Editor at Pharma Business Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Sullivan, Timothy R.; Nelson, Jeffrey, filed on July 26, 2011, was published online on March 14, 2017. The patent's assignee for patent number 9592354 is Mystic Pharmaceuticals, Inc.. News editors obtain
3/27/17 - Researchers from Pusan National University Hospital Describe Findings in Drug Delivery Systems [Synthesis of methoxy poly(ethylene...
By a News Reporter-Staff News Editor at Nanotechnology Weekly Investigators discuss new findings in Drugs and Therapies- Drug Delivery Systems. According to news originating from Pusan, South Korea, by VerticalNews correspondents, research stated, "The ebselen has radio-protective effect. Our news journalists obtained a quote from the research fr
3/27/17 - Researchers from University of Verona Describe Findings in Biopharmaceuticals (Edible plants for oral delivery of biopharmaceuticals)
According to news originating from Verona, Italy, by NewsRx correspondents, research stated, "Molecular farming is the use of plants for the production of high value recombinant proteins. Our news journalists obtained a quote from the research from the University of Verona, "One of the most promising approaches is the use of edible plant organs exp
3/27/17 - Researchers Submit Patent Application, "Pharmaceutical Solution Formulations for Pressurised Metered Dose Inhalers", for Approval (USPTO 20170065518)
By a News Reporter-Staff News Editor at Pharma Business Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors LEWIS, DAVID ANDREW; MEAKIN, BRIAN JOHN; BRAMBILLA, GAETANO, filed on November 17, 2016, was made available online on March 16, 2017. The patent's assignee is Chiesi Farmaceutici S.p.a. News edit
3/27/17 - Study Results from University of Verona Broaden Understanding of Biopharmaceuticals (Edible plants for oral delivery of biopharmaceuticals)
The news reporters obtained a quote from the research from the University of Verona, "One of the most promising approaches is the use of edible plant organs expressing biopharmaceuticals for direct oral delivery. For more information on this research see: Edible plants for oral delivery of biopharmaceuticals. British Journal of Clinical Pharmacolog
3/27/17 - Today in history
Two airliners carrying American and European tourists crashed into each other and burned at Tenerife North Airport in the Canary Islands, a Spanish archipelago off the coast of Morocco. FDA approves the use of Viagra to treat impotence. The Food and Drug Administration approved the use of the drug Viagra, an oral medication that treats impotence.
3/25/17 - Lupin gets approval in inhalation space [Syrian Arab News Agency]
It received final approval for its Tobramycin Inhalation Solution USP, 300 mg/5 ml from US Food and Drug Administration to market a generic version of Novartis Pharmaceuticals` TOBI 300 mg/5 ml. Lupin has the fifth largest pipeline of ANDA filings pending approval with US FDA 134 product filings pending approval. Cumulative Filings with the US FD
3/25/17 - Pharma & Healthcare Newsletter March 20 to March 24, 2017 [India Infoline News Service]
This week, "The US Food and Drug Administration has added one more clause in its import alert given to the drug maker, Divi's Laboratories Limited." Pharma Major Lupin Limited announced today that it has received final approval for its Tobramycin Inhalation Solution USP, 300 mg/5 ml from the United States Food and Drug Administration to market a ge
3/25/17 - Provision Of Amgros 2017-1.851.a. [TendersInfo (India)]
Contract notice: Provision of Amgros 2017-1.851. a. Contract number includes the following products: Invitation to tender: 1, ATC code: J02AX04, Generic Name: Caspofungin, Pharmaceutical form: Infusion Strength: 50 mg, Unit Value: 50 mg, Quantity in Units 2 550th Invitation to tender: 1, ATC code: J02AX04, Generic Name: Caspofungin, Pharmaceutical
3/24/17 - Analyst Activity Piper Jaffray Companies Initiates Coverage On Zosano Pharma Corp (NASDAQ:ZSAN) With a Overweight
Analyst Ratings For Zosano Pharma Corp (NASDAQ:ZSAN) Today, Piper Jaffray Companies initiated coverage on Zosano Pharma Corp (NASDAQ:ZSAN) with a Overweight. There are 1 hold rating, 2 buy ratings on the stock. The current consensus rating on Zosano Pharma Corp (NASDAQ:ZSAN) is Buy (Score: 2.67) with a consensus target price of $3.00 per share, a [
3/24/17 - Bharat Book Bureau: Global Transdermal Patch Market
"Global Transdermal Patch Market& Clinical Pipeline Outlook 2022" report discusses the ongoing clinical and non-clinical parameters with respect to development of global transdermal patch market. Report highlights the need for integration of transdermal patches in existing drug delivery methodology available to pharmaceutical companies.
3/24/17 - CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board [T-break Tech (Middle East)]
-CURE Pharmaceutical, or, a leading disruptive drug delivery technology company serving the pharmaceutical, biotech, veterinarian, medical foods markets, cannabinoid molecules and new chemical entities, today announces the appointment of Michael Neely, MD, 47, to its Advisory Board. Michael Neely, MD, currently serves as acting chief of infectious
3/24/17 - FDA Approves Increased Shelf Life and In-Use Storage at Room Temperature for Orfadin nitisinone
By a News Reporter-Staff News Editor at Drug Week Sobi, a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families, announced that the FDA approved a supplemental new drug application for Orfadin capsules in the U.S. The sNDA will allow
3/24/17 - FDA Approves Symproic (naldemedine) Once-Daily Tablets C-II for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain
OSAKA, Japan& FLORHAM PARK, N.J.& STAMFORD, Conn. Shionogi Inc. and Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration approved Symproic 0.2 mg tablets C-II as a once-daily oral peripherally-acting mu-opioid receptor antagonist medication for the treatment of opioid-induced constipation in adult patients with chron
3/24/17 - FDA Grants Approval for BAVENCIO (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Release date- 23032017- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. today announced that the US Food and Drug Administration has approved BAVENCIO Injection 20 mg/mL, for intravenous use, for the treatment of adults and pediatric patients 12 years and older with metastatic Merke
3/24/17 - Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine
Release date- 23032017- WINNIPEG- Medicure Inc., a leading Canadian specialty pharmaceutical company, is pleased to announce that its majority-owned subsidiary, Apicore Inc., has received final approval from the U.S. Food and Drug Administration for the Company's abbreviated new drug application for tetrabenazine tablets in the 12.5 mg and 25 mg st
Articles(s): 1 - 25 of 87     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415